Actively Recruiting
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
Led by Peking Union Medical College Hospital · Updated on 2024-03-01
150
Participants Needed
1
Research Sites
273 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with neuroendocrine tumors mainly in pheochromocytoma and paraganglioma (PPGL) and neuroblastoma (NB).
CONDITIONS
Official Title
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The participant has read, signed, and dated an informed consent form before any study procedures.
- Patient has histologically confirmed or clinically suspected neural crest tumor.
- Neuroblastoma patients should have 123I-MIBG scintigraphy within 6 months before or scheduled within 3 months after inclusion.
- Participant is male or a nonpregnant, nonlactating female who is surgically sterile or post-menopausal.
- Participant is able and willing to comply with all study procedures as described.
You will not qualify if you...
- Patients who are pregnant, possibly pregnant, or breastfeeding.
- Patients undergoing surgery between selection and inclusion visits.
- Patients who may become pregnant or wish to become pregnant during the study period (including their partners).
- Patients deemed unsuitable by researchers to participate in the trial.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking union medical college hospital
Beijing, Dongcheng, China, 100010
Actively Recruiting
Research Team
P
Peipei Wang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here